期刊文献+

外周血CD34^+细胞绝对计数可靠预示自体外周血干细胞采集效果 被引量:5

Peripheral blood CD34^+ cell absolute count reliably predicts peripheral blood progenitor cell autograft CD34^+ cell content
原文传递
导出
摘要 目的 为确定外周血CD34+细胞绝对计数能否可靠预示自体外周血干细胞的采集效果。方法 用流式细胞仪ProCOUNT方法对采集的 2 5份次移植物和采集当天外周血行CD34+细胞绝对计数 ,同时做外周血常规检查和移植物集落形成单位 (CFU)计数 ,每份次移植物以CD34+/kg ,单个核细胞 (MNC) /kg,粒 巨噬细胞集落形成单位 (CFU GM) /kg ,红细胞集落形成单位 (CFU E) /kg等为指标 ,与患者采集当天的外周血CD34+细胞绝对计数、CD34+细胞百分比、WBC ,MNC ,中性粒细胞(NEU)或血小板 (PLT)等各项指标进行相关分析和逐步回归分析。结果  ( 1)Spearman相关分析结果 :外周血CD34+细胞绝对计数与移植物CD34+/kg高度相关 (r=0 790 ,P <0 0 0 1) ,外周血CD34+细胞百分比与移植物CD34+/kg相关 (r=0 6 17,P <0 0 5 )。外周血WBC、MNC、NEU、PLT或RBC与移植物CD34+/kg无关。外周血CD34+细胞绝对计数与移植物CFU E相关 ,而与CFU GM无关。外周血MNC与移植物MNC/kg相关。 ( 2 )逐步回归分析结果 :移植物CD34+/kg只与外周血CD34+细胞绝对计数高度相关 (P <0 0 0 1) ,而与外周血CD34+细胞百分比无关。结论 移植物CD34+/kg只与外周血CD34+细胞绝对计数高度相关 。 Objective To study whether peripheral blood (PB)CD34+ cell absolute count can reliably predict peripheral blood progenitor cell (PBPC) autograft CD34+ cell contents. Methods We examined the PB CD34+ cell count and PBPC CD34+ cell count with ProCOUNT by flow cytometry. Twenty-five collections were performed.The PBPC autograft parameters measured were the CD34+ cell?CFU-GM? CFU-E?BFU-E?CFU-MK and mononuclear cell (MNC) content. We analyzed the correlation between the PB CD34+ cell absolute count?CD34+%?WBC?NEU?MNC?PLT? RBC and Various parameters in the PBPC autograft with Spearman correlations analysis or Regression analysis. Results (1) There is a strong correlation between PB CD34+ cell/L and autograft CD34+ cell/kg (r=0.790,P<0.001). There is no correlation between autograft CD34+/kg and PB CD34%?PB WBC?PB NEU?PB MNC?PB PLT or PB RBC. (2) There is correlation between PB CD34+ cell/L and PBPC CFU-E. (3) There is correlation between PB MNC and PBPC MNC/kg. Conclusions There is only strong correlation between PB CD34+ cell/L and PBPC CD34+/kg. So PB CD34+ cell absolute count can reliably predict PBPC CD34+ count.
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2003年第1期13-16,共4页 Chinese Journal of Laboratory Medicine
关键词 细胞绝对计数 CD34 外周血干细胞移植 移植物 Antigens, CD34 Flow cytometry
  • 相关文献

参考文献12

  • 1Bender JG;To LB;Williams S.Defining a therapeutic dose of peripheral blood stem cells,1992.
  • 2Sutherland DR;Stewart AK;Keating A.CD34 antigen:molecular features and potential clinical applications,1995(Suppl 3).
  • 3To LB.The biology and clinical uses of blood stem cells,1997.
  • 4Bensinger WI;Longin K;Appelbaum F.Peripheral blood stem cells collected after recombinant granulocyte colony stimulating factor (rh G-CSF) :an analysis of factors collecting with engraftment after transplantation[J],1994(87).
  • 5To LB;Shepperd KM;Haylock DN.Single high doses of cyclophosphamide enable the collection of high numbers of hemopoietic stem cells from the peripheral blood,1990.
  • 6Rabimwitz AP;Watkins K;Groshen S.Peripheral blood stem cells harvested during marrow recovery from disease-specific chemotherapy shorten duration of neutropenia in patients undergoing autologous bone marrow transplantation[J],1993.
  • 7Chang E;Parker J;Groshen S.Comparison of progenitor cell content in sequential peripheral blood progenitor collections after mobilization with chemotherapy and GM-CSF[J],1998(2).
  • 8Elliot C;Samson DM;Armitage S.When to harvest peripheral blood stem cells after mobilization therapy:prediction of CD34-positive cell yield by preceding day CD34-positive concentration in peripheral blood,1996.
  • 9北京市临床流式细胞分析协作组.流式细胞术三色分析调查成年人外周血CD34^+造血干细胞绝对计数参考范围[J].中华检验医学杂志,2002,25(1):58-60. 被引量:15
  • 10Sutherlan DK;Anderson L.The ISHAGE Guidelines for CD34+cell determination by flow cytometry,1996.

二级参考文献12

  • 1Rizzo D. New summary slides show current trends in BMT. ABMTR Newsletter 1998; 5(1):4-10.
  • 2To LB, Haylock DN, Simmons PJ, et al. The biology and clinical uses & 127 of blood stem cells. Blood 1997;89:2233-2258
  • 3Sutherlan DR, Anderson L. The ISHAGE Guidelines for CD34+ cell determination by flow cytometry. J hematotherapy 1996;5:213-226
  • 4Johnsen HE. Report from a Nordic Workshop on CD34+ cell analysis: Technical recommendations for progenitor cell enumeration in leukapheresis from multiple myeloma patients. J hematotherapy 1995;4:21-28
  • 5Johnsen HE, Nordic. Flow cytometry standards for CD34+ cell enumeration in blood and leukapheresis products: report from Second Nordic Workshop. J hematotherapy 1996;5:237-245
  • 6Brecher ME, Sims L, Schmitz J, et al. North American multicenter study on flow cytometric enumeration of CD34+ hematopoietic stem cells. J hematotherapy 1996;5:227-236 .
  • 7Lowdell MW, Bainbrige DR. External quality assurance for CD34+ cell enumeration result for a preliminary national trail: Bone Marrow Transplantation 1996;17:849-853
  • 8Gross HJ, Verwer BJH, Houck D, et al. Detection of rare cell at a frequency of one per million by flow cytometry. Cytometry 1993;14:519-526
  • 9McCarthy RC, Fetterhoff TJ. Issues for quality assurance in clinical flow cytometry. Arch Pathol Lab Med 1989;113:658-666
  • 10Loken MR, Owens Ma. Flow cytometry principles for clinical Laboratory practice, quality assurance for quantitative immunophenotyping, Wiley-Liss, New york. 1995:11-13

共引文献15

同被引文献33

  • 1杨红,麦玉洁,邱录贵.多发性骨髓瘤的造血干细胞移植治疗现状及策略[J].白血病.淋巴瘤,2005,14(1):61-64. 被引量:2
  • 2安秀云,克晓燕,肖辉.影响机采外周血干细胞收集量的相关因素及临床应用[J].北京大学学报(医学版),2005,37(2):220-221. 被引量:3
  • 3Auer RL, Holtom P,Smith H,et al. Circulating CD34+ counts and apheresis planning [J ]. Hematol Oncol, 1998 ; 16(2):69.
  • 4Lefrere F,Delarue R,Somme D,et al. High-dose CD34+ cells are not clinically relevant in reducing cytopenia and blood component consumption following myeloablative therapy and peripheral blood progenitor cell transplantation as compared with standard dose[J]. Transfusion, 2002 ; 42(4) : 443.
  • 5Bender JG, To LB, Williams S, et al. DefiLfing a therapeutic dose of peripheral blood stem cells[J].J Hematother, 1992 ; 1(4):329.
  • 6Armitage S,Hargreaves R,Samson D,et al. CD34+ counts to predict the adequate collection of peripheral blood progenitor cells[J]. Bone Marrow Transplant, 1997 : 20 (7) : 587-591.
  • 7Lefrere F,Delarue R,Somme D,et al. High-dose CD34+ cells are not clinically relevant in reducing cytopenia and blood component consumption following myeloablative therapy and peripheral blood progenitor cell transplantation as compared with standard dose[
  • 8Auer RL. Holtom P,Smith H,et al,Circulating CD34+counts and apheresis planning [J]. Hematol Oncol, 1998; 16(2):69.
  • 9Bender JG,To LB,Williams S,et al. Defining a therapeutic dose of peripheral blood stem cells[J]. J Hematother, 1992 ; 1(4) :329.
  • 10Armitage S,Hargreaves R,Samson D,et al. CD34+ counts to predict the adequate collection of peripheral blood progenitor cells[J]. Bone Marrow Transplant, 1997: 20(7): 587-591.

引证文献5

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部